1. Home
  2. CYH vs ANGO Comparison

CYH vs ANGO Comparison

Compare CYH & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Community Health Systems Inc.

CYH

Community Health Systems Inc.

SELL

Current Price

$2.02

Market Cap

411.7M

Sector

Health Care

ML Signal

SELL

Logo AngioDynamics Inc.

ANGO

AngioDynamics Inc.

SELL

Current Price

$11.51

Market Cap

420.2M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CYH
ANGO
Founded
1985
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
411.7M
420.2M
IPO Year
2000
2004

Fundamental Metrics

Financial Performance
Metric
CYH
ANGO
Price
$2.02
$11.51
Analyst Decision
Hold
Strong Buy
Analyst Count
10
4
Target Price
$2.51
★ $19.75
AVG Volume (30 Days)
★ 2.2M
552.7K
Earning Date
10-28-2026
01-05-2027
Dividend Yield
N/A
N/A
EPS Growth
★ 196.67
N/A
EPS
N/A
★ N/A
Revenue
★ $12,485,000,000.00
$291,010,000.00
Revenue This Year
N/A
$5.47
Revenue Next Year
N/A
$5.10
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 10.17
52 Week Low
$2.04
$9.39
52 Week High
$3.92
$16.29

Technical Indicators

Market Signals
Indicator
CYH
ANGO
Relative Strength Index (RSI) 33.59 38.07
Support Level $2.04 $10.57
Resistance Level $3.04 $11.66
Average True Range (ATR) 0.18 0.48
MACD -0.01 0.06
Stochastic Oscillator 3.06 0.38

Price Performance

Historical Comparison
CYH
ANGO

About CYH Community Health Systems Inc.

Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.

About ANGO AngioDynamics Inc.

AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.

Share on Social Networks: